Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...

Ozempic can help manage type 2 diabetes, but it's also becoming increasingly popular for weight loss, which is an off-label use. Clinical trials show that Ozempic's active ingredient, semaglutide ...

Artificial intelligence (AI) has the potential to transform several different areas of the healthcare industry.

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

A leading voice in the U.S. health insurance sector recently signaled a potential surge in costs, a warning that resonates ...

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries at risk of ineffective treatments and potentially fatal side effects, an ...

First Reading is a Canadian politics newsletter curated by the National Post’s own Tristin Hopper. To get an early version ...

While Medicaid covers such medications, Medicare, on its own, does not ... Researchers are also looking into whether GLP-1 medications like Ozempic and Wegovy, which have been “effective for ...